发明名称 |
Adrenomedullin and adrenomedullin binding protein for ischemia/reperfusion treatment |
摘要 |
Methods of treating a mammal at risk for ischemia-reperfusion injury are provided. The methods comprise administrating an adrenomedullin binding protein-1 (AMBP-1) to the mammal in sufficient amount to reduce the injury. Also provided are methods of treating a mammal at risk for ischemia-reperfusion injury to the bowel. The methods comprise administering adrenomedullin to the mammal in sufficient amount to reduce the injury. |
申请公布号 |
US9101593(B2) |
申请公布日期 |
2015.08.11 |
申请号 |
US201414193284 |
申请日期 |
2014.02.28 |
申请人 |
The Feinstein Institute for Medical Research |
发明人 |
Wang Ping |
分类号 |
A61K38/22;A61K38/17 |
主分类号 |
A61K38/22 |
代理机构 |
Amster, Rothestein & Ebenstein LLP |
代理人 |
Amster, Rothestein & Ebenstein LLP |
主权项 |
1. A method of treating a mammal at risk for ischemia-reperfusion injury to a kidney, the method comprising administering an amount of adrenomedullin binding protein-1 (AMBP-1) and adrenomedullin to the mammal effective to reduce ischemia-reperfusion injury to a mammalian kidney. |
地址 |
Manhasset NY US |